Overview

the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

Status:
Not yet recruiting

Trial end date:
2020-09-11

Target enrollment:

Participant gender:

Summary

The present study is a randomized clinical trial, with the approval of the ethics committee will be conducted on patients who have a positive test confirming COVID-19 in Loghman Hakim Medical Education Center in Tehran. Patients will be randomly assigned to the two arms of the study and after completing the course of treatment and collecting and analyzing the necessary information from each patient, the results of the study will be published both on this site and in the form of an article in a reputable international journal.

Phase:

Phase 2

Details

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Treatments:

Interferon beta-1a
Interferon-beta
Interferons
Lopinavir
Ritonavir